Literature DB >> 4200542

Effect of heat-labile factors on the neutralization of vaccinia virus by human.

K Takabayashi, K McIntosh.   

Abstract

The effect of unheated guinea pig and human prevaccination serum on the neutralization of vaccinia virus was studied. Enhancement of neutralization was found in all sera containing antibody and was more marked (20- to 150-fold) in sera obtained in the first weeks after primary vaccination than in sera from immune adults or cord sera (4- to 25-fold). The enhancing factor was thought to be complement because it was destroyed by heating and ethylenediaminetetraacetic acid treatment. The fresh serum-enhanced neutralization test represents a highly sensitive and specific test which can be applied to measure low levels of vaccinia antibody not detectable by other means.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4200542      PMCID： PMC422895          DOI： 10.1128/iai.8.4.582-589.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  23 in total

1.  Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin.

Authors:  W K Ashe; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

2.  Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.

Authors:  B Hampar; A L Notkins; M Mage; M A Keehn
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

3.  Herpes simplex neutralizing antibody--quantitation of the complement-dependent fraction in different phases of adult human infection.

Authors:  H S Heineman
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

4.  Evaluation of the demonstration of complement-requiring neutralizing antibody as a means for early diagnosis of herpes virus infections.

Authors:  K Yoshino; S Taniguchi
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

5.  Complement requirement of the neutralizing antibody appearing after immunization with smallpox vaccine.

Authors:  C Nishimura; M Nomura; M Kitaoka; Y Takeuchi; M Kimura
Journal:  Jpn J Microbiol       Date:  1968-06

6.  The morphological and biological effects of various antisera on avian infectious bronchitis virus.

Authors:  D M Berry; J D Almeida
Journal:  J Gen Virol       Date:  1968-07       Impact factor: 3.891

7.  Rubella virus neutralization by plaque reduction.

Authors:  W E Rawls; J Desmyter; J L Melnick
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

8.  Experiences with improvement of the neutralization reaction with vaccinia virus in chick fibroblast cultures.

Authors:  O A Aksenov; A A Smorodintsev
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1966

9.  Effect of complement and viral filtration on the neutralization of respiratory syncytial virus.

Authors:  R H Baughman; J D Fenters; G S Marquis; J C Holper
Journal:  Appl Microbiol       Date:  1968-07

10.  Smallpox vaccination of eczema patients with attenuated live vaccinia virus.

Authors:  C H Kempe
Journal:  Yale J Biol Med       Date:  1968-08
View more
  6 in total

1.  Neutralization kinetics studies with type SAT2 foot-and-mouth disease virus strains. 1. Factors that influence the rate and pattern of neutralization.

Authors:  M M Rweyemamu; J C Booth; T W Pay
Journal:  J Hyg (Lond)       Date:  1977-02

2.  Viral antibodies in cerebrospinal fluid of multiple sclerosis and control patients: comparison between radioimmunoassay and conventional techniques.

Authors:  B Forghani; N E Cremer; K P Johnson; A H Ginsberg; W H Likosky
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques.

Authors:  Laura Evgin; Sergio A Acuna; Christiano Tanese de Souza; Monique Marguerie; Chantal G Lemay; Carolina S Ilkow; C Scott Findlay; Theresa Falls; Kelley A Parato; David Hanwell; Alyssa Goldstein; Roberto Lopez; Sandra Lafrance; Caroline J Breitbach; David Kirn; Harold Atkins; Rebecca C Auer; Joshua M Thurman; Gregory L Stahl; John D Lambris; John C Bell; J Andrea McCart
Journal:  Mol Ther       Date:  2015-03-25       Impact factor: 11.454

Review 4.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

5.  Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus.

Authors:  T N Kaul; R C Welliver; P L Ogra
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

6.  Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.

Authors:  Stephanie Downs-Canner; Zong Sheng Guo; Roshni Ravindranathan; Caroline J Breitbach; Mark E O'Malley; Heather L Jones; Anne Moon; Judith Andrea McCart; Yongli Shuai; Herbert J Zeh; David L Bartlett
Journal:  Mol Ther       Date:  2016-05-16       Impact factor: 11.454
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.